Evidence map›Paper›PMID 27806376›Full record

ArticleNature2016

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma.

Itay Tirosh, Andrew S Venteicher, Christine Hebert, Leah E Escalante, Anoop P Patel, Keren Yizhak, Jonathan M Fisher, Christopher Rodman, Christopher Mount, Mariella G Filbin and 28 more

Open access · bronzeAbstract read
In one paragraph

Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 767 papers.

0numbers the graph read from it
0cells of the map it votes in
767citing papers in PubMed
52.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

767 citing papers in PubMed, 1,295 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

707 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

38 authors at 7 institutions in 1 country.

Itay TiroshBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Andrew S VenteicherBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Christine HebertBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Leah E EscalanteBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Anoop P PatelDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Keren YizhakBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Jonathan M FisherBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Christopher RodmanBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Christopher MountDepartments of Neurology, Neurosurgery, Pediatrics and Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.
Mariella G FilbinBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Cyril NeftelBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Niyati DesaiDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Jackson NymanBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Benjamin IzarBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Christina C LuoDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Joshua M FrancisBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Aanand A PatelDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Maristela L OnozatoDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Nicolo RiggiDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Kenneth J LivakBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Dave GennertBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Rahul SatijaBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Brian V NahedDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
William T CurryDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Robert L MartuzaDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Ravindra MylvaganamDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
A John IafrateDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Matthew P FroschDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Todd R GolubBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Miguel N RiveraBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Gad GetzBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Orit Rozenblatt-RosenBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Daniel P CahillDepartment of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Michelle MonjeDepartments of Neurology, Neurosurgery, Pediatrics and Pathology, Stanford University School of Medicine, Stanford, California 94305, USA.
Bradley E BernsteinBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
David N LouisDepartment of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
Aviv RegevBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Mario L SuvàBroad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA.
Broad Institute · USMassachusetts General Hospital · USHarvard University · USCenter for Cancer Research · USDana-Farber Cancer Institute · USStanford Medicine · USHoward Hughes Medical Institute · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Michael Birnbaum · 1985 to 2026
$93.9M
Neuroscience Resident Research ProgramR25NS065743 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI CASH, SYDNEY S, WILLIAMS, ZIV · 2009 to 2023
$11.8M
Trinity: Transcriptome assembly for genetic and functional analysis of cancerU24CA180922 · NCI · BROAD INSTITUTE, INC. · PI HAAS, BRIAN · 2013 to 2022
$7.5M
Neuroscience Resident Research ProgramUE5NS065743 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI SYDNEY S CASH, Ziv Williams · 2024 to 2026
$2.6M
An integrated multiplexed genomic assay for low input clinical samples1U24AI118672 · NIAID · BROAD INSTITUTE, INC. · PI SHALEK, ALEX K · 2015 to 2019
$2.0M
Clinical implementation of single cell tumor transcriptome analysisR33CA202820 · NCI · BROAD INSTITUTE, INC. · PI GOLUB, TODD R., JOHNSON, BRUCE E. · 2016 to 2018
$1.3M
Translational Immunology Core's FACSAria Cell SorterS10RR023440 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2008 to 2008
$500k
Howard Hughes Medical InstituteNCI NIH HHS 1U24CA180922NCI NIH HHS P30 CA014051NCI NIH HHS R33 CA202820NCI NIH HHS U24 CA180922NCRR NIH HHS S10 RR023440NIAID NIH HHS U24 AI118672NINDS NIH HHS R25 NS065743NINDS NIH HHS UE5 NS065743
6 · The paper itself

Abstract

Although human tumours are shaped by the genetic evolution of cancer cells, evidence also suggests that they display hierarchies related to developmental pathways and epigenetic programs in which cancer stem cells (CSCs) can drive tumour growth and give rise to differentiated progeny. Yet, unbiased evidence for CSCs in solid human malignancies remains elusive. Here we profile 4,347 single cells from six IDH1 or IDH2 mutant human oligodendrogliomas by RNA sequencing (RNA-seq) and reconstruct their developmental programs from genome-wide expression signatures. We infer that most cancer cells are differentiated along two specialized glial programs, whereas a rare subpopulation of cells is undifferentiated and associated with a neural stem cell expression program. Cells with expression signatures for proliferation are highly enriched in this rare subpopulation, consistent with a model in which CSCs are primarily responsible for fuelling the growth of oligodendroglioma in humans. Analysis of copy number variation (CNV) shows that distinct CNV sub-clones within tumours display similar cellular hierarchies, suggesting that the architecture of oligodendroglioma is primarily dictated by developmental programs. Subclonal point mutation analysis supports a similar model, although a full phylogenetic tree would be required to definitively determine the effect of genetic evolution on the inferred hierarchies. Our single-cell analyses provide insight into the cellular architecture of oligodendrogliomas at single-cell resolution and support the cancer stem cell model, with substantial implications for disease management.

Indexed as

Sequence Analysis, RNASingle-Cell AnalysisCell DifferentiationCell ProliferationDNA Copy Number VariationsHumansIsocitrate DehydrogenaseNeoplastic Stem CellsNeural Stem CellsNeurogliaOligodendrogliomaPhylogenyPoint MutationIDH1 protein, humanIDH2 protein, humanIsocitrate Dehydrogenase

Identifiers

PMID27806376
PMCPMC5465819
OpenAlexW2546514099

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.